Equity Research, Broker Reports, and media content on Amryt Pharma PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Amryt Pharma PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Amryt Pharma PLC

Company Profile

  • Personnel
  • Joe Wiley, CEO
  • Rory Nealon , CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Amryt Pharma PLC. We currently have 169 research reports from 5 professional analysts.

  • Open: 174p
  • Range Today: 173/177p
  • 52 Week: 148/230p
  • Daily Volume: 25.5k
  • Daily Liquidity: (0.01%)
  • # Shares: 316.1m
  • Market Cap: £549.1m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
13Sep21 12:00 GNW Amryt Raises Full Year 2021 Revenue Guidance to $220M - $225M
01Sep21 07:00 GNW Total Voting Rights
19Aug21 07:00 GNW Amryt Issues Ordinary Shares and Total Voting Rights
13Aug21 13:23 RNS Amryt Pharma PLC - Holding(s) in Company - Replacement
11Aug21 11:30 RNS Amryt Pharma PLC - Holdings in Company
11Aug21 10:36 RNS Amryt Pharma PLC - Holding(s) in Company
10Aug21 14:20 GNW Director/PDMR Shareholding
  • Frequency of research reports

     

  • Research reports on

    Amryt Pharma PLC

  • Providers covering

    Amryt Pharma PLC